Novo Nordisk Seeks Supplier Discounts Amid Intensifying Obesity Drug Competition

Pharmaceutical giant Novo Nordisk is reportedly seeking discounts from its suppliers as the competitive landscape for obesity treatment drugs becomes increasingly intense. This move suggests a strategic effort to manage costs in a rapidly evolving market.